Zimvie (ZIMV) | Stock Overview & Key Data
Zimvie Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $50.40 on February 14, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Mar 31, 2025
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Zimvie
ZIMV
|
535.72M | 0.05% | 0.58% | 1.23% | 112.89% | 103.32% | 36.91% | 131.59% | -57.04% | -57.04% | -57.04% | -57.04% |
| 160.70B Large-cap | -2.02% | 4.97% | -19.35% | -30.98% | -28.60% | -34.98% | -16.97% | -20.08% | 135.84% | 255.56% | 329.52% | |
| 97.63B Large-cap | -3.98% | -11.24% | -33.00% | -49.28% | -50.63% | -52.97% | -13.64% | 9.04% | 108.58% | 590.87% | 133.50% | |
|
Procept BioRobotics
PRCT
|
1.37B Small-cap | -18.10% | -11.10% | -17.04% | -35.68% | -24.51% | -57.61% | -25.83% | -35.75% | -35.75% | -35.75% | -35.75% |
|
QuidelOrtho
QDEL
|
765.24M Small-cap | 0.69% | 41.18% | -17.45% | -49.86% | -49.37% | -51.11% | -83.87% | -87.58% | -19.62% | -6.61% | 40.60% |
|
Enovis
ENOV
|
1.31B Small-cap | -11.40% | -13.63% | -9.61% | -20.95% | -20.86% | -31.66% | -63.77% | -70.90% | -55.34% | -45.40% | -38.21% |
Ownership & Short Interest
Calculate Your Zimvie Investment Returns
Long-Term Investment Performance Analysis
Zimvie stock price in Feb 2022 was $44.20, A $1,000.00 lump sum investment in Zimvie made 3 years ago would be worth approximately $429.64 today, representing a negative return of -57.04%. This translates to an annualized return (CAGR) of -20.50%.
3 Years 8 Months Investment Scenario (Feb 2022 - Oct 2025)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ZIMV's 52-week high and low?
- In the last 52 weeks, Zimvie reached a high of $19.01 (on N/A) and a low of $8.15 (on May 23, 2025).
- What is the market cap and P/E ratio for ZIMV?
- Curious about Zimvie's size and valuation? Its market capitalization stands at 535.72M. When it comes to valuation, the P/E ratio (trailing twelve months) is -20.20, and the forward P/E (looking ahead) is 28.77.
- Does ZIMV pay dividends? If so, what's the yield?
- As for dividends, Zimvie isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Zimvie's main competitors or similar companies to consider before investing?
When looking at Zimvie, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT160.70B Healthcare Medical Devices -34.98% -16.97% Boston Scientific
BSX97.63B Healthcare Medical Devices -52.97% -13.64% Procept BioRobotics
PRCT1.37B Healthcare Medical Devices -57.61% -25.83% QuidelOrtho
QDEL765.24M Healthcare Medical Devices -51.11% -83.87% Enovis
ENOV1.31B Healthcare Medical Devices -31.66% -63.77% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Zimvie Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Zimvie's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -4.76%, the Debt to Equity ratio from the most recent quarter is 56.82, and its Gross Profit Margin stands at 64.55%.
- What is the recent revenue and earnings growth for ZIMV?
- Looking at Zimvie's growth, its revenue over the trailing twelve months (TTM) was $443M. Compared to the same quarter last year (YoY), quarterly revenue grew by -0.10%, and quarterly earnings saw a YoY growth of -0.13%.
- How much of ZIMV stock is held by insiders and institutions?
- Wondering who owns Zimvie stock? Company insiders (like executives and directors) hold about 2.73% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 90.96%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.